`

Tagged: Pfizer-BioNTech

COVID-19 vaccine booster for children aged 12–15.

January 11th, 2022 | Pfizer-BioNTech

The FDA reviewed data from Israel from children 12–15 years old who received a booster five months after the primary Pfizer-BioNTech COVID-19 vaccine and is amending the Emergency Use Authorization (EUA) to allow the booster five months after the primary two-dose vaccination for children aged 12–15. In addition, real-world data that has become available provide […]

Pin It on Pinterest